Name: Beyond PD-L1: Personalizing Immunotherapy in Genomic Subsets of Advanced NSCLC
Start: 2026-09-14T18:45:00+09:00
End: 2026-09-14T19:45:00+09:00

Sign up for news updates

Timely and relevant thoracic oncology news brought to you by the only true global association dedicated to the multi-disciplinary study of lung cancer.

Timely and relevant thoracic oncology news brought to you by the only true global association dedicated to the multi-disciplinary study of lung cancer.

Beyond PD-L1: Personalizing Immunotherapy in Genomic Subsets of Advanced NSCLC

Details